<p>Fresenius Medical Care AG（ETR:FME - 獲取免費報告）的股票在週四的交易中突破了其 200 日移動平均線。該股票的 200 日移動平均線為€42.56（$47.29），最高交易價為€45.73（$50.81）。Fresenius Medical Care 的股票最後交易價為€45.57（$50.63），成交量為 408,811 股。</p>
<p>獲取 <strong>Fresenius Medical Care</strong> 的提醒：</p>
<h2>Fresenius Medical Care 價格表現</h2>
<p>該股票的 50 日移動平均線為€45.58，200 日移動平均線為€42.56。公司的債務與股本比率為 82.24，速動比率為 0.80，流動比率為 1.37。該股票的市值為 137.9 億美元，市盈率為 20.93，市盈增長比率為 0.42，貝塔值為 0.86。</p>
<h2>Fresenius Medical Care 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Fresenius Medical Care AG 在德國、北美及國際上為腎臟疾病患者提供透析及相關服務。該公司通過門診透析診所網絡提供透析治療及相關實驗室和診斷服務；提供材料、培訓和患者支持服務，包括臨牀監測、後續協助以及安排將物資送到患者住所；併為美國醫院的住院終末期腎病（ESRD）患者和急性腎衰竭患者提供合同透析服務。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票，勝過 Fresenius Medical Care</li>
<li>什麼是股息挑戰者？</li>
<li>RH 的股票下跌近 40%：投資者現在可以轉向哪裏</li>
<li>技術指標如何幫助你找到被超賣的股票</li>
<li>關税、分拆和 R2 更新是 Rivian 的積極信號</li>
<li>股票回購是什麼？投資者的全面指南</li>
<li>Cathie Wood 大量購買百度——現在是購買的合適時機嗎？</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資$1,000 在 Fresenius Medical Care 嗎？</h2>
<p>在考慮 Fresenius Medical Care 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛市場注意到之前立即購買的股票……而 Fresenius Medical Care 並不在名單上。</p>
<p>雖然 Fresenius Medical Care 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Fresenius Medical Care（ETR:FME）股票已突破其 200 日移動平均線 42.56 歐元，目前交易價格為 45.57 歐元，市值為 137.9 億美元。該股票的市盈率為 20.93，貝塔值為 0.86。分析師目前將其評級為持有，但建議有更好的投資選擇。該公司專注於為各個地區的腎病患者提供透析服務</p>

<p>Shares of Fresenius Medical Care AG (ETR:FME - Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €42.56 ($47.29) and traded as high as €45.73 ($50.81). Fresenius Medical Care shares last traded at €45.57 ($50.63), with a volume of 408,811 shares traded.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG（ETR:FME - 獲取免費報告）的股票在週四的交易中突破了其 200 日移動平均線。該股票的 200 日移動平均線為€42.56（$47.29），最高交易價為€45.73（$50.81）。Fresenius Medical Care 的股票最後交易價為€45.57（$50.63），成交量為 408,811 股。</p>
</div><p>Get <strong>Fresenius Medical Care</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Fresenius Medical Care</strong> 的提醒：</p>
</div><h2>Fresenius Medical Care Price Performance</h2>
<div class="lb-trans"><h2>Fresenius Medical Care 價格表現</h2>
</div><p>The stock's 50 day moving average is €45.58 and its two-hundred day moving average is €42.56. The company has a debt-to-equity ratio of 82.24, a quick ratio of 0.80 and a current ratio of 1.37. The stock has a market capitalization of $13.79 billion, a PE ratio of 20.93, a price-to-earnings-growth ratio of 0.42 and a beta of 0.86.</p>
<div class="lb-trans"><p>該股票的 50 日移動平均線為€45.58，200 日移動平均線為€42.56。公司的債務與股本比率為 82.24，速動比率為 0.80，流動比率為 1.37。該股票的市值為 137.9 億美元，市盈率為 20.93，市盈增長比率為 0.42，貝塔值為 0.86。</p>
</div><h2>Fresenius Medical Care Company Profile</h2>
<div class="lb-trans"><h2>Fresenius Medical Care 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.</p>
<div class="lb-trans"><p>Fresenius Medical Care AG 在德國、北美及國際上為腎臟疾病患者提供透析及相關服務。該公司通過門診透析診所網絡提供透析治療及相關實驗室和診斷服務；提供材料、培訓和患者支持服務，包括臨牀監測、後續協助以及安排將物資送到患者住所；併為美國醫院的住院終末期腎病（ESRD）患者和急性腎衰竭患者提供合同透析服務。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Fresenius Medical Care</li>
<li>What Are Dividend Challengers?</li>
<li>Shares of RH Down Nearly 40%: Where Investors Can Turn To Now</li>
<li>How Technical Indicators Can Help You Find Oversold Stocks</li>
<li>Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian</li>
<li>What is a buyback in stocks? A comprehensive guide for investors</li>
<li>Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 Fresenius Medical Care</li>
<li>什麼是股息挑戰者？</li>
<li>RH 的股票下跌近 40%：投資者現在可以轉向哪裏</li>
<li>技術指標如何幫助你找到被超賣的股票</li>
<li>關税、分拆和 R2 更新是 Rivian 的積極信號</li>
<li>股票回購是什麼？投資者的全面指南</li>
<li>Cathie Wood 大量購買百度——現在是購買的合適時機嗎？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快和最準確的報道。此故事在發佈前已由 MarketBeat 的編輯團隊審核。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Fresenius Medical Care Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資$1,000 在 Fresenius Medical Care 嗎？</h2>
</div><p>Before you consider Fresenius Medical Care, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Fresenius Medical Care 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户在更廣泛市場注意到之前立即購買的股票……而 Fresenius Medical Care 並不在名單上。</p>
</div><p>While Fresenius Medical Care currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Fresenius Medical Care 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

費森尤斯醫療（ETR:FME）股價突破 200 日移動平均線 - 你應該賣出嗎？